Parametric Portfolio Associates’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,098
Closed -$455K 3631
2021
Q1
$455K Sell
2,098
-1,310
-38% -$246K ﹤0.01% 3545
2020
Q4
$393K Sell
3,408
-254
-7% -$28.5K ﹤0.01% 3480
2020
Q3
$356K Sell
3,662
-45,002
-92% -$5.18M ﹤0.01% 3418
2020
Q2
$5.97M Sell
48,664
-14,488
-23% -$1.64M ﹤0.01% 1752
2020
Q1
$5.53M Buy
63,152
+17,057
+37% +$1.81M 0.01% 1658
2019
Q4
$4.82M Buy
46,095
+8,059
+21% +$904K ﹤0.01% 2091
2019
Q3
$4.38M Buy
38,036
+32,697
+612% +$4.96M ﹤0.01% 2109
2019
Q2
$920K Buy
5,339
+432
+9% +$74.7K ﹤0.01% 3088
2019
Q1
$827K Sell
4,907
-17
-0.3% -$2.53K ﹤0.01% 3121
2018
Q4
$480K Buy
4,924
+502
+11% +$65.9K ﹤0.01% 3331
2018
Q3
$764K Buy
4,422
+843
+24% +$122K ﹤0.01% 3236
2018
Q2
$499K Buy
3,579
+195
+6% +$27.7K ﹤0.01% 3348
2018
Q1
$381K Sell
3,384
-9
-0.3% -$1.13K ﹤0.01% 3479
2017
Q4
$448K Sell
3,393
-41
-1% -$4.82K ﹤0.01% 3387
2017
Q3
$349K Buy
3,434
+39
+1% +$4.18K ﹤0.01% 3610
2017
Q2
$340K Sell
3,395
-1,737
-34% -$187K ﹤0.01% 3573
2017
Q1
$621K Buy
5,132
+903
+21% +$111K ﹤0.01% 3099
2016
Q4
$473K Sell
4,229
-3,241
-43% -$390K ﹤0.01% 3216
2016
Q3
$991K Sell
7,470
-5,493
-42% -$525K ﹤0.01% 2809
2016
Q2
$1.19M Buy
12,963
+6,216
+92% +$523K ﹤0.01% 2697
2016
Q1
$487K Buy
6,747
+3,419
+103% +$188K ﹤0.01% 3348
2015
Q4
$231K Hold
3,328
﹤0.01% 3673
2015
Q3
$304K Hold
3,328
﹤0.01% 2956
2015
Q2
$409K Hold
3,328
﹤0.01% 3399
2015
Q1
$303K Hold
3,328
﹤0.01% 3550
2014
Q4
$225K Buy
+3,328
New +$243K ﹤0.01% 3723

Other funds holding GWPH

Parametric Portfolio Associates's GWPH Position: Q2 2021 in Review

Parametric Portfolio Associates sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 2,098 shares — an estimated $455K sold.

Parametric Portfolio Associates first reported a position in GWPH in Q4 2014 and held it in 26 quarters. The position peaked at $5.97M in Q2 2020. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Parametric Portfolio Associates reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Parametric Portfolio Associates sold 2,098 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $455K.
  • Parametric Portfolio Associates first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2014 and held it in 26 quarters.
  • Parametric Portfolio Associates's GW Pharmaceuticals Plc American Depositary Shares position peaked at $5.97M in Q2 2020.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Parametric Portfolio Associates's 13F filing for Q2 2021, filed 13 Aug 2021.